Holen Sie sich die Stockscreener-App
21.81
3.79%
-0.86
Schlusskurs vom Vortag:
$22.67
Offen:
$22.49
24-Stunden-Volumen:
1.30M
Relative Volume:
1.13
Marktkapitalisierung:
$2.92B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.09M
KGV:
-13.98
EPS:
-1.56
Netto-Cashflow:
$-160.51M
1W Leistung:
+38.65%
1M Leistung:
+27.47%
6M Leistung:
+27.84%
1J Leistung:
+44.44%
1-Tages-Spanne:
$21.47
$22.84
1-Wochen-Bereich:
$15.83
$23.24
52-Wochen-Spanne:
$9.60
$23.24
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Firmenname
Centessa Pharmaceuticals Plc Adr
Sektor
Branche
Telefon
44 7391 789784
Adresse
3RD FLOOR, ALTRINCHAM, CHESHIRE
Vergleichen Sie CNTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
21.81 | 3.04B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-29 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-05-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2023-11-15 | Hochstufung | Jefferies | Hold → Buy |
| 2023-10-26 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Eingeleitet | Evercore ISI | Outperform |
| 2023-06-12 | Eingeleitet | Guggenheim | Buy |
| 2023-03-17 | Eingeleitet | SVB Securities | Outperform |
| 2022-08-12 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Fred Alger Management LLC Cuts Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharma chief technology officer sells $1m in shares - Investing.com
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighHere's What Happened - MarketBeat
What is Lifesci Capital's Forecast for CNTA Q3 Earnings? - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap UpHere's What Happened - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 19.1 USD By Investing.com - Investing.com Australia
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Acquired by Cutter Capital Management LP - MarketBeat
Cormorant Asset Management LP Lowers Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 19.1 USD - Investing.com
Alibaba, Palantir Lead Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa
Alibaba, Palantir Lead Market Cap Stock Movers on Monday - Investing.com
Palantir, EchoStar lead market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Palantir, EchoStar lead market cap stock movers on Monday - Investing.com India
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 9.1%Here's What Happened - MarketBeat
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA is First Light Asset Management LLC's 3rd Largest Position - MarketBeat
Nantahala Capital Management LLC Increases Stock Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
What is Lifesci Capital’s Forecast for CNTA Q3 Earnings? - Defense World
Armistice Capital LLC Makes New $6.73 Million Investment in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Driehaus Capital Management LLC Sells 502,650 Shares of Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Siren L.L.C. Has $42.57 Million Stock Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Wellington Management Group LLP Has $2 Million Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
HighTower Advisors LLC Raises Holdings in Onto Innovation Inc. $ONTO - Defense World
American Century Companies Inc. Increases Stake in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
American Century Companies Inc. Buys 83,678 Shares of AdvanSix $ASIX - Defense World
Microsoft Corporation $MSFT Shares Bought by SilverOak Wealth Management LLC - Defense World
American Century Companies Inc. Increases Position in Mizuho Financial Group, Inc. $MFG - Defense World
Vanguard Group Inc. Has $59.77 Million Holdings in Sturm, Ruger & Company, Inc. $RGR - Defense World
Russell Investments Group Ltd. Invests $3.27 Million in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - Defense World
FY2025 Earnings Estimate for CNTA Issued By Chardan Capital - Defense World
Equities Analysts Issue Forecasts for CNTA FY2025 Earnings - Defense World
Centessa Pharma general counsel sells $103k in shares By Investing.com - Investing.com South Africa
Centessa Pharma general counsel sells $103k in shares - Investing.com India
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 - Placera.se
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025 - GlobeNewswire Inc.
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Bank of New York Mellon Corp Buys Shares of 10,257 Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) - Defense World
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA): On Track To A Higher Share Price - stocksregister.com
The Future of Centessa Pharmaceuticals plc ADR: Analyzing CNTA - investchronicle.com
Centessa Pharma (CNTA) CBO Weinhoff sells $155,598 in shares By Investing.com - Investing.com India
Centessa Pharma (CNTA) CBO Weinhoff sells $155,598 in shares - Investing.com
Cerity Partners LLC Invests $471,000 in Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) - Defense World
Centessa Pharmaceuticals plc ADR Inc. (CNTA) Price Performance: A Fundamental Analysis Perspective - investchronicle.com
Taseko Mines Ltd: Navigating Market Fluctuations with a 1.09B Market Cap - investchronicle.com
Codere Online Luxembourg (NASDAQ:CDRO) & Take-Two Interactive Software (NASDAQ:TTWO) Critical Analysis - Defense World
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Average Rating of “Buy” by Analysts - Defense World
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 3.8% After Insider Selling - Defense World
Centessa Pharmaceuticals’ Accardi sells $210,000 in shares - Investing.com
Centessa Pharma CEO Saha sells $694,826 in shares - Investing.com
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):